It is an immunotherapy and the FDA has specifically warned against stopping these trials too early. Also you can't really count from 2007. 2012 is a better starting point. Still a long trial but it has only been 2.3 years since the last patient was enrolled and around 80 or so are less than 3 years from enrollment.